메뉴 건너뛰기




Volumn 9, Issue 7, 2016, Pages 646-656

Effect of Pre-Hospital Ticagrelor during the First 24 h after Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction the ATLANTIC-H24 Analysis

(209)  Montalescot, Gilles a   Van 'T Hof, Arnoud W b   Bolognese, Leonardo c   Cantor, Warren J d,t   Cequier, Angel e   Chettibi, Mohamed f   Collet, Jean Philippe a   Goodman, Shaun G g   Hammett, Christopher J h,t   Huber, Kurt i   Janzon, Magnus j   Lapostolle, Frédéric k   Lassen, Jens Flensted l   Licour, Muriel m   Merkely, Béla n   Salhi, Néjoua m   Silvain, Johanne a   Storey, Robert F o   Ten Berg, Jurriën M p   Tsatsaris, Anne m   more..


Author keywords

myocardial infarction; platelets; reperfusion; stents; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT;

EID: 84959464492     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.12.024     Document Type: Article
Times cited : (39)

References (17)
  • 1
    • 84922391666 scopus 로고    scopus 로고
    • Prehospital ticagrelor in ST-segment elevation myocardial infarction
    • G. Montalescot, A.W. van 't Hof, F. Lapostolle, and et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction N Engl J Med 371 2014 1016 1027
    • (2014) N Engl J Med , vol.371 , pp. 1016-1027
    • Montalescot, G.1    Van 'T Hof, A.W.2    Lapostolle, F.3
  • 2
    • 84922391666 scopus 로고    scopus 로고
    • Prehospital ticagrelor in ST-segment elevation myocardial infarction (letter)
    • G. Montalescot, and A.W. van 't Hof Prehospital ticagrelor in ST-segment elevation myocardial infarction (letter) N Engl J Med 371 2014 2339
    • (2014) N Engl J Med , vol.371 , pp. 2339
    • Montalescot, G.1    Van 'T Hof, A.W.2
  • 3
    • 84875467706 scopus 로고    scopus 로고
    • Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study
    • G. Montalescot, J.F. Lassen, C.W. Hamm, and et al. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study Am Heart J 165 2013 515 522
    • (2013) Am Heart J , vol.165 , pp. 515-522
    • Montalescot, G.1    Lassen, J.F.2    Hamm, C.W.3
  • 4
    • 84858760413 scopus 로고    scopus 로고
    • Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting
    • The FABOLUS PRO (Facilitation through Aggrastat by drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial
    • M. Valgimigli, M. Tebaldi, G. Campo, and et al. Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial J Am Coll Cardiol Intv 5 2012 268 277
    • (2012) J Am Coll Cardiol Intv , vol.5 , pp. 268-277
    • Valgimigli, M.1    Tebaldi, M.2    Campo, G.3
  • 5
    • 84988457258 scopus 로고    scopus 로고
    • A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI
    • S. Koul, P. Andell, A. Martinsson, and et al. A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI BMC Cardiovasc Disord 14 2014 189
    • (2014) BMC Cardiovasc Disord , vol.14 , pp. 189
    • Koul, S.1    Andell, P.2    Martinsson, A.3
  • 6
    • 84893372406 scopus 로고    scopus 로고
    • Preventive angioplasty in myocardial infarction
    • D.S. Wald, J.K. Morris, and N.J. Wald Preventive angioplasty in myocardial infarction N Engl J Med 370 2014 283
    • (2014) N Engl J Med , vol.370 , pp. 283
    • Wald, D.S.1    Morris, J.K.2    Wald, N.J.3
  • 7
    • 20144373281 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
    • M.S. Sabatine, C.P. Cannon, C.M. Gibson, and et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
    • (2005) N Engl J Med , vol.352 , pp. 1179-1189
    • Sabatine, M.S.1    Cannon, C.P.2    Gibson, C.M.3
  • 8
    • 33745229963 scopus 로고    scopus 로고
    • The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: The ECG CLARITY-TIMI 28 Study
    • B.M. Scirica, M.S. Sabatine, D.A. Morrow, and et al. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study J Am Coll Cardiol 48 2006 37 42
    • (2006) J Am Coll Cardiol , vol.48 , pp. 37-42
    • Scirica, B.M.1    Sabatine, M.S.2    Morrow, D.A.3
  • 9
    • 44249122195 scopus 로고    scopus 로고
    • Bivalirudin during primary PCI in acute myocardial infarction
    • G.W. Stone, B. Witzenbichler, G. Guagliumi, and et al. Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
    • (2008) N Engl J Med , vol.358 , pp. 2218-2230
    • Stone, G.W.1    Witzenbichler, B.2    Guagliumi, G.3
  • 10
    • 71849119604 scopus 로고    scopus 로고
    • Intravenous platelet blockade with cangrelor during PCI
    • D.L. Bhatt, A.M. Lincoff, C.M. Gibson, and et al. Intravenous platelet blockade with cangrelor during PCI N Engl J Med 361 2009 2330 2341
    • (2009) N Engl J Med , vol.361 , pp. 2330-2341
    • Bhatt, D.L.1    Lincoff, A.M.2    Gibson, C.M.3
  • 11
    • 84875779761 scopus 로고    scopus 로고
    • Effect of platelet inhibition with cangrelor during PCI on ischemic events
    • D.L. Bhatt, G.W. Stone, K.W. Mahaffey, and et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med 368 2013 1303 1313
    • (2013) N Engl J Med , vol.368 , pp. 1303-1313
    • Bhatt, D.L.1    Stone, G.W.2    Mahaffey, K.W.3
  • 12
    • 0035927938 scopus 로고    scopus 로고
    • Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
    • G. Montalescot, P. Barragan, O. Wittenberg, and et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
    • (2001) N Engl J Med , vol.344 , pp. 1895-1903
    • Montalescot, G.1    Barragan, P.2    Wittenberg, O.3
  • 13
    • 72949090599 scopus 로고    scopus 로고
    • Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: A meta-regression analysis of randomized trials
    • G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
    • (2009) Eur Heart J , vol.30 , pp. 2705-2713
    • De Luca, G.1    Navarese, E.2    Marino, P.3
  • 14
    • 77954785933 scopus 로고    scopus 로고
    • Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: Insights from the APEX-AMI trial
    • K. Huber, D.R. Holmes Jr., A.W. van 't Hof, and et al. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial Eur Heart J 31 2010 1708 1716
    • (2010) Eur Heart J , vol.31 , pp. 1708-1716
    • Huber, K.1    Holmes, D.R.2    Van 'T Hof, A.W.3
  • 15
    • 0037187893 scopus 로고    scopus 로고
    • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
    • G.W. Stone, C.L. Grines, D.A. Cox, and et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
    • (2002) N Engl J Med , vol.346 , pp. 957-966
    • Stone, G.W.1    Grines, C.L.2    Cox, D.A.3
  • 16
    • 49149128492 scopus 로고    scopus 로고
    • Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): A multicentre, double-blind, randomised controlled trial
    • A.W. van 't Hof, J.M. ten Berg, T. Heestermans, and et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial Lancet 372 2008 537 546
    • (2008) Lancet , vol.372 , pp. 537-546
    • Van 'T Hof, A.W.1    Ten Berg, J.M.2    Heestermans, T.3
  • 17
    • 84922328786 scopus 로고    scopus 로고
    • Ticagrelor crushed tablets administration in STEMI patients: The MOJITO study
    • G. Parodi, I. Xanthopoulou, B. Bellandi, and et al. Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study J Am Coll Cardiol 65 2015 511 512
    • (2015) J Am Coll Cardiol , vol.65 , pp. 511-512
    • Parodi, G.1    Xanthopoulou, I.2    Bellandi, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.